Danny Gerrits
Impact in
-
- Peptidase Inhibition and Analysis
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Melanoma and MAPK Pathways 1
- Oncology 3
- Peptidase Inhibition and Analysis 2
- Cutaneous Melanoma Detection and Management 1
- Co-authors
- Otto C. Boerman (9 shared papers)Peter Laverman (5 shared papers)Josbert M. Metselaar (4 shared papers)Kanefusa Kato (1 shared paper)Jeffrey Robbins (1 shared paper)Wilfried W. de Jong (1 shared paper)Wim J.G. Oyen (4 shared papers)Wilbert C. Boelens (1 shared paper)
- Journals
- Journal of Nuclear Medicine (4 papers)Journal of Controlled Release (2 papers)Neuropharmacology (1 paper)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- NetherlandsSwitzerlandGermany
In The Last Decade
Danny Gerrits
11 papers receiving 307 citations
Peers
Comparison fields: 5 of 56
- Oncology 112
- Radiology, Nuclear Medicine and Imaging 72
- Cancer Research 41
- Molecular Biology 119
- Rheumatology 24
Countries citing papers authored by Danny Gerrits
This map shows the geographic impact of Danny Gerrits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Gerrits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Gerrits more than expected).
Fields of papers citing papers by Danny Gerrits
This network shows the impact of papers produced by Danny Gerrits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Gerrits. The network helps show where Danny Gerrits may publish in the future.
Co-authors
The 25 scholars most cited alongside Danny Gerrits, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 87 | |
| 2 | 2005 | 65 | |
| 3 | 2016 | 32 | |
| 4 | 2015 | 26 | |
| 5 | 2015 | 23 | |
| 6 | 2015 | 22 | |
| 7 | 2017 | 18 | |
| 8 | 2014 | 15 | |
| 9 | 2014 | 8 | |
| 10 | 2016 | 6 | |
| 11 | 2018 | 5 |
About Danny Gerrits
Danny Gerrits is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cellular and Molecular Neuroscience, having authored 11 papers that have together received 307 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Prostate Cancer Treatment and Research (1 paper), MRI in cancer diagnosis (1 paper), Cutaneous Melanoma Detection and Management (1 paper), Melanoma and MAPK Pathways (1 paper) and Inhalation and Respiratory Drug Delivery (1 paper). The work is most often cited by research in Oncology (112 citations), Radiology, Nuclear Medicine and Imaging (72 citations), Cancer Research (41 citations), Molecular Biology (119 citations) and Rheumatology (24 citations). Danny Gerrits has collaborated with scholars based in Netherlands, Switzerland and Germany. Frequent co-authors include Otto C. Boerman, Peter Laverman, Josbert M. Metselaar, Kanefusa Kato, Jeffrey Robbins, Wilfried W. de Jong, Wim J.G. Oyen, Wilbert C. Boelens, John den Engelsman and Samantha Y.A. Terry. Their work appears in journals such as Journal of Nuclear Medicine, Journal of Controlled Release, Neuropharmacology, European Journal of Nuclear Medicine and Molecular Imaging and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.